Kamran Hosseini | Biochemistry | Best Researcher Award

Published on by Academic Achievements

Best Researcher Award

Kamran Hosseini
Affiliation Shiraz University of Medical Sciences
Country Iran
Scopus ID 57226155096
Documents 32
Citations 638
h-index 10
Subject Area Biochemistry, Genetics and Molecular Biology
Event International Academic Achievements & Awards
ORCID 0000-0003-1189-7143

Kamran Hosseini
Shiraz University of Medical Sciences, Iran

The Best Researcher Award recognizes distinguished scholars whose sustained scientific achievements, publication record, research quality, and academic influence demonstrate excellence within their respective disciplines. Kamran Hosseini has established an active research profile in biochemistry, genetics, molecular biology, neuroscience, and clinical medicine through peer-reviewed publications addressing neurological disorders, molecular signaling pathways, spinal surgery, and translational biomedical research.[1] His scholarly output, citation impact, and international visibility provide evidence of continued contributions to medical science and interdisciplinary biomedical research.[2]

Abstract

Kamran Hosseini has contributed to contemporary biomedical research through investigations spanning molecular biology, neurology, neurosurgery, gene therapy, spinal disorders, and translational medicine. His publication portfolio demonstrates interdisciplinary collaboration while integrating laboratory discoveries with clinical applications. Current research includes viral vector-mediated therapeutic strategies, spinal surgery outcomes, neurological disease mechanisms, and complex neurosurgical case management.[3] Such work reflects sustained engagement with evidence-based medicine and translational biomedical science.

Keywords

Best Researcher Award, Kamran Hosseini, Neuroscience, Molecular Biology, Gene Therapy, AAV Vectors, Biochemistry, Genetics, Neurosurgery, Clinical Research, Biomedical Science, Translational Medicine, Shiraz University of Medical Sciences.

Introduction

Recognition through a Best Researcher Award is commonly based upon sustained scholarly productivity, measurable research impact, publication quality, interdisciplinary collaboration, and contributions to scientific advancement. Researchers working across molecular biology and clinical medicine play an important role in translating laboratory discoveries into practical healthcare improvements.[1] Kamran Hosseini’s research activities illustrate this translational approach by integrating basic biological science with clinical neurosurgical investigations.

Research Profile

  • Affiliation: Shiraz University of Medical Sciences
  • Primary discipline: Biochemistry, Genetics and Molecular Biology
  • Scopus documents: 32
  • Total citations: 638
  • Scopus h-index: 10
  • Research interests include neuroscience, molecular signaling pathways, neurosurgery, spinal disorders, translational medicine, and gene therapy.

Research Contributions

The research portfolio demonstrates contributions across molecular neuroscience, neurological disorders, spinal surgery, and clinical case studies. Recent investigations evaluate adeno-associated virus (AAV) vectors for therapeutic modulation of cellular signaling pathways, assess perioperative interventions to reduce blood loss during spinal fusion procedures, and document rare neurosurgical cases that contribute to evidence-based clinical decision making.[3] These publications illustrate interdisciplinary collaboration between molecular biology and clinical neuroscience while supporting translational healthcare research.

Publications

  • AAV Vector‐Mediated Modulation of Signaling Pathways in Neurological Disorders, Cell Biochemistry and Function (2026). DOI: 10.1002/cbf.70270.
  • Prophylactic effects of tranexamic acid in spinal fusion, Egyptian Journal of Neurosurgery (2026). DOI: 10.1186/s41984-026-00560-8.
  • Giant Lumbosacral Meningioma Without Dural Attachment in an Adolescent, International Medical Case Reports Journal (2026). DOI: 10.2147/IMCRJ.S578462.
  • Management of Intrathoracic Huge Meningocele in Neurofibromatosis Type-1, International Medical Case Reports Journal (2026). DOI: 10.2147/IMCRJ.S578419.
  • Kümmell’s Disease in Benign Vertebral Compression Fractures, Clinical Neurology and Neurosurgery (2026). DOI: 10.1016/j.clineuro.2025.109262.

Research Impact

Available bibliometric indicators demonstrate an established publication record comprising 32 indexed documents, 638 citations, and an h-index of 10. These metrics indicate continued scholarly engagement and measurable scientific visibility within biomedical research.[1] The combination of molecular biology, neuroscience, and clinical investigations contributes to interdisciplinary knowledge relevant to both research laboratories and healthcare practice.

Award Suitability

Based on the available academic profile, publication activity, citation performance, interdisciplinary research scope, and contributions to peer-reviewed biomedical literature, Kamran Hosseini demonstrates characteristics commonly evaluated for academic recognition programs such as the Best Researcher Award. His research integrates molecular science with clinical application while contributing to neurological disease research, spinal surgery, and translational medicine through internationally published scientific work.[2]

Conclusion

Kamran Hosseini’s scholarly record reflects sustained participation in biomedical research characterized by interdisciplinary collaboration, clinically relevant investigations, and measurable academic impact. His publication portfolio, citation metrics, and recent contributions to neuroscience and molecular biology illustrate a research trajectory aligned with internationally recognized standards of scientific excellence and make his profile appropriate for consideration within academic recognition initiatives.

References

  1. Elsevier. (n.d.). Scopus author details: Kamran Hosseini, Author ID 57226155096. Scopus.
    https://www.scopus.com/pages/authors/57226155096
  2. ORCID. (n.d.). Kamran Hosseini ORCID Record.
    https://orcid.org/0000-0003-1189-7143
  3. Hosseini K. et al. (2026). AAV Vector‐Mediated Modulation of Signaling Pathways in Neurological Disorders: Insights From Cellular, Animal, and Human Studies. Cell Biochemistry and Function. DOI: https://doi.org/10.1002/cbf.70270
  4. Hosseini K. et al. (2026). Prophylactic effects of tranexamic acid in spinal fusion. Egyptian Journal of Neurosurgery. https://doi.org/10.1186/s41984-026-00560-8
  5. Recent peer-reviewed publications in International Medical Case Reports Journal and Clinical Neurology and Neurosurgery (2026). https://doi.org/10.2147/IMCRJ.S578462

Promise Paul | Biochemistry | Innovative Research Award

Published on by Academic Achievements

Innovative Research Award

Promise Paul
Affiliation Michael Okpara University of Agriculture, Umudike
Country Nigeria
Google Scholar ID o4j7GMIAAAAJ
Documents 6
Citations 24
h-index 1
Subject Area Biochemistry
Event International Academic Achievements & Awards
ORCID 0009-0002-7532-8409

Researcher: Promise Paul
Institution: Michael Okpara University of Agriculture, Umudike

Promise Paul is a researcher affiliated with Michael Okpara University of Agriculture, Umudike, Nigeria, whose scholarly activities are centered on biochemistry, toxicology, environmental health, immunology, and emerging public health technologies. His published research demonstrates interdisciplinary collaboration involving biochemical mechanisms, environmental risk assessment, immunomodulation, and artificial intelligence applications in healthcare. Based on the available scholarly record, his work reflects an emphasis on translating laboratory findings into practical biomedical and public health applications.[1][2]

Abstract

Promise Paul has contributed to a growing body of interdisciplinary research spanning biochemical sciences, environmental toxicology, occupational exposure assessment, immunology, and public health. His publications investigate volatile organic compound interactions with biological receptors, bioaccumulation of toxic elements in aquatic organisms, antioxidant mechanisms, immune regulation, and artificial intelligence applications in disease surveillance. Collectively, these studies contribute to understanding disease prevention, environmental safety, and biomedical innovation while supporting evidence-based public health practices.[2][3]

Keywords

Biochemistry, Environmental Toxicology, Occupational Health, Drug Design, Artificial Intelligence, Public Health, Immunology, Oxidative Stress

Introduction

Modern biomedical research increasingly depends on interdisciplinary collaboration to address complex health and environmental challenges. Promise Paul’s research portfolio reflects this approach by integrating biochemical investigation with environmental science, clinical perspectives, and computational technologies. His collaborative publications examine toxicological mechanisms, disease prevention, environmental monitoring, and innovative analytical strategies that support scientific understanding across multiple disciplines.[2]

Research Profile

The available publication record indicates research interests spanning molecular toxicology, pharmacology, environmental biochemistry, immunomodulation, veterinary science, and digital public health. His collaborative studies frequently investigate biological responses to toxic compounds, mechanisms of oxidative stress, environmental contaminants, and innovative approaches for disease surveillance using artificial intelligence technologies. These areas collectively contribute to improving scientific understanding of health risks and preventive strategies.[1]

Research Contributions

  • Investigated volatile organic compound interactions with drug receptors to support rational drug discovery strategies.
  • Contributed to environmental health studies evaluating toxic element bioaccumulation in commercially important fish species.
  • Participated in immunology research examining therapeutic approaches for congenital immunodeficiencies.
  • Co-authored research exploring ethical implementation of artificial intelligence for public health surveillance.
  • Investigated antioxidant effects of L-Arginine against carbon tetrachloride-induced oxidative damage in experimental animal models.

Publications

  1. Volatile organic compound–drug receptor interactions: a potential tool for drug design in the search for remedies for increasing toxic occupational exposure. Processes, 13(1), 154. DOI: https://doi.org/10.3390/pr13010154
  2. Bioaccumulation and Human Health Risk Assessment of Potentially Toxic Elements in Commercial Fish Species. International Journal of Environmental Research and Public Health, 23(7), 827.
  3. Immunomodulation in Congenital Immunodeficiencies: Targeting Innate and Adaptive Pathways. Clinical Medicine and Integrative Therapies, 1(1), 36–52.
  4. Artificial Intelligence for Public Health Surveillance: Promises, Pitfalls, and an Ethics-Equity Roadmap for Deployment. Disease Prevention and Epidemiology, 1(1), 22–39.
  5. Antioxidant Effects of L-Arginine on Redox Profile of Carbon Tetrachloride (CCl4)-Intoxicated Albino Rats. Journal of Sustainable Veterinary & Allied Sciences, 7(4), 385–391.

Research Impact

Although currently representing an early-stage publication profile, the available scholarly metrics indicate growing visibility through peer-reviewed publications and citations. The interdisciplinary nature of these investigations contributes to knowledge spanning environmental safety, biomedical science, toxicology, and digital health while encouraging collaboration across multiple scientific disciplines.[2]

Award Suitability

Promise Paul’s research portfolio demonstrates characteristics commonly considered for emerging research recognition, including interdisciplinary collaboration, publication in peer-reviewed journals, investigation of contemporary biomedical and environmental issues, and contributions to public health research. The Innovative Research Award appropriately recognizes researchers developing multidisciplinary scientific approaches with potential societal relevance.[1][2]

Conclusion

Promise Paul has established an emerging interdisciplinary research profile focused on biochemistry, environmental health, immunology, toxicology, and artificial intelligence applications in medicine. His collaborative publications demonstrate scientific engagement with important biomedical and environmental challenges, supporting continued academic development and making his work consistent with the objectives of recognizing innovative scientific research.

References

  1. Google Scholar. (n.d.). Promise Paul – Google Scholar Citations Profile.
    https://scholar.google.com/citations?user=o4j7GMIAAAAJ&hl=en&oi=ao
  2. Processes. (2025). Volatile organic compound–drug receptor interactions: a potential tool for drug design in the search for remedies for increasing toxic occupational exposure.DOI:https://doi.org/10.3390/pr13010154
  3. ORCID. (n.d.). Promise Paul ORCID Record.
    https://orcid.org/0009-0002-7532-8409
  4. Crossref DOI Foundation. (n.d.). DOI Metadata and Scholarly Record Services.